Vistagen Therapeutics (VTGN) Cash from Operations (2009 - 2026)
Vistagen Therapeutics (VTGN) reported Cash from Operations of -$12.19 million for fiscal Q2 2027 (quarter ended Sep 30, 2026), compared with -$13.76 million a year earlier.
Vistagen Therapeutics (VTGN) Cash from Operations (2009 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Vistagen Therapeutics' Cash from Operations came in at -$60.73 million; for FY2026 (ended Mar 31, 2026), it came in at -$66.44 million.
- By fiscal year, Cash from Operations came in at -$42.1 million in FY2025, -$25.81 million in FY2024, -$49.72 million in FY2023 and -$45.26 million in FY2022.
- The fiscal Q2 2027 figure ranks as the highest quarterly Cash from Operations since fiscal Q4 2025.
- Per Business Quant data, the three fiscal quarters before Q2 2027 came in at -$14.71 million (Q1 2027), -$16.2 million (Q4 2026) and -$17.63 million (Q3 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | PetVivo Holdings | 3,096.39 Bn | 3,096.39 Bn | 196,075.00 | -947,041.00 |
| 2 | Eli Lilly | 1,202.70 Bn | 1,176.32 Bn | 20.46 Bn | 11.40 Bn |
| 3 | Johnson & Johnson | 649.77 Bn | 569.63 Bn | 17.30 Bn | 7.72 Bn |
| 4 | AbbVie | 507.00 Bn | 475.00 Bn | 13.12 Bn | 7.61 Bn |
| 5 | Merck | 329.70 Bn | 292.64 Bn | 13.19 Bn | 6.56 Bn |
| 6 | Novartis Ag | 291.91 Bn | 265.14 Bn | - | - |
| 7 | Amgen | 236.26 Bn | 187.91 Bn | 7.58 Bn | 4.24 Bn |
| 8 | Gilead Sciences | 207.15 Bn | 182.26 Bn | 6.73 Bn | 5.04 Bn |
| 9 | Gsk | 193.54 Bn | 176.38 Bn | - | - |
| 10 | Vistagen Therapeutics | 7.34 Mn | -151.60 Mn | - | -12.19 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -12.19 Mn |
| Jun 30, 2026 | -14.71 Mn |
| Mar 31, 2026 | -16.20 Mn |
| Dec 31, 2025 | -17.63 Mn |
| Sep 30, 2025 | -13.76 Mn |
| Jun 30, 2025 | -18.85 Mn |
| Mar 31, 2025 | -10.06 Mn |
| Dec 31, 2024 | -10.28 Mn |
| Sep 30, 2024 | -10.89 Mn |
| Jun 30, 2024 | -10.87 Mn |
| Mar 31, 2024 | -6.99 Mn |
| Dec 31, 2023 | -4.75 Mn |
| Sep 30, 2023 | -6.19 Mn |
| Jun 30, 2023 | -7.89 Mn |
| Mar 31, 2023 | -7.47 Mn |
| Dec 31, 2022 | -9.93 Mn |
| Sep 30, 2022 | -16.34 Mn |
| Jun 30, 2022 | -15.97 Mn |
| Mar 31, 2022 | -15.59 Mn |
| Dec 31, 2021 | -12.05 Mn |
Vistagen Therapeutics Cash from Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-operations&ticker=VTGN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-operations", "ticker": "VTGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-operations&ticker=VTGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();